Boston Scientific Shuffles and Sells in Bid to Right Ship

Boston Scientific, in a bid to raise capital and focus its efforts, is selling off lower priority businesses as well as its stakes in nearly 100 private and public companies.

More from Business Strategy

More from In Vivo